Articles

Building brand loyalty through holistic customer management

24th July 2014

Building brand loyalty through holistic customer managementJenny Cowderoy

Pharma companies are looking at non-related industries with a track record in digital innovation to benchmark their own digital activities, but overall they continue to make slow progress in digital... Read more

Tunnah’s musings: The difference between listening and understanding

23rd July 2014

Tunnah’s musings: The difference between listening and understandingPaul Tunnah

The pharmaceutical industry has always been obsessed with conducting extensive research to underpin its activities, but Paul Tunnah wonders whether, in our quest to analyse everything to the highest level... Read more

A digital revolution for patient care

22nd July 2014

A digital revolution for patient careSunil Rao

The digital maturity of life sciences companies will change significantly in the next three years as digital technology yields a wealth of data that provides opportunities to drive more innovation,... Read more

CCGs – the story behind the headlines and implications for market rese…

21st July 2014

CCGs – the story behind the headlines and implications for market researchJudy Norcross

Why the recruitment, screening and sampling process needs to work harder in market research to understand the needs, behaviours, priorities, and attitudes in CCGs.The NHS reforms introduced in 2013 were... Read more

News

Sandoz files biosimilar application

24th July 2014

Sandoz files biosimilar applicationLinda Banks

Sandoz has had its Biologics Licence Application for filgrastim accepted by the US FDA.The application was filed under the new biosimilar pathway created in the Biologics Price Competition and Innovation... Read more

Gilead's leukaemia drug Zydelig gains US approval

24th July 2014

Gilead's leukaemia drug Zydelig gains US approvalAndrew McConaghie

Gilead's Zydelig, one of a generation of new treatments set to advance the treatment of chronic lymphocytic leukemia (CLL), has been approved by the FDA.Zydelig ((idelalisib) is a new oral... Read more

BMS and Ono to collaborate on immunotherapy combinations in Japan

24th July 2014

BMS and Ono to collaborate on immunotherapy combinations in JapanAndrew McConaghie

Plans for the first global launch of Opdivo, the first in a new class of immunotherapy which promise a major advance in cancer treatment, are moving ahead in Japan.Japanese pharma... Read more

NICE recommends drugs for blood clots and constipation

23rd July 2014

NICE recommends drugs for blood clots and constipationLinda Banks

UK healthcare guidance body NICE has recommended drugs targeting blood clots and constipation. It has reviewed its 2009 guidance on prasugrel (Efient, Eli Lilly and Co) and now recommends the drug... Read more

Audio & Video

Webinar: 9 July - The future of UK pharm…

WEBINAR COVER smaller


The global pharmaceutical market passes a significant milestone in 2014: reaching one trillion US dollars in total value. IMS Health... View more

Rare Disease Day tweetchat

 

To view a full transcript of the discussion from this #hcsmeu tweetchat held on 28th February 2014 please click View more

Is there common ground for engagement be…

Doctors net webinar

 

The growth of online networks for doctors has been accompanied by recognition from the pharmaceutical industry that these digital meeting grounds can be... View more

Executive Perspectives: Jane Griffiths

 

In the latest in our series of interviews with senior executives who are steering the global pharma industry through a period of unparalleled change, pharmaphorum... View more

White Papers

Diabetes in France

Diabetes in FranceJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Diabetes in Germany

Diabetes in GermanyJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Connected data and the use of smartphone…

Connected data and the use of smartphone enabled apps in market researchPaul Mannu

Rapid growth in smartphone usage offers healthcare researchers a useful tool to gain better understanding of how patients and healthcare professionals actually behave on a daily basis. Inaccuracies can arise... View info

Diabetes in the UK

Diabetes in the UKJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Further News & Articles

Shire growth shows AbbVie's interest goes beyond tax

The headline news in AbbVie's pursuit of Shire may be the opportunity to reduce its tax, but Shire's second-q... Read more

News

Allergan cuts workforce as part of restructure

Allergan has announced that about 13 per cent of its workforce will go as part of a restructure in the second... Read more

News

Pharma companies offer up compounds to UK researchers

Seven pharmaceutical companies have agreed to grant UK academic researchers access to a virtual library of 'depr... Read more

News

HIV community mourns lost colleagues

The start of the International Aids Conference in Melbourne this week has been overshadowed by the tragic dea... Read more

News

Pharma's fixation on amyloid misguided, says TauRx chair

The pharma industry's dogged determination to develop amyloid-targeting therapies for Alzheimer's disease is ... Read more

News

AbbVie and Shire merger agreed

AbbVie and Shire have announced that their long-awaited merger is to go ahead, following AbbVie's f... Read more

News